Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Medtronic plcMDT · Entity 2888 | EVP & Pres Neuroscience | May 26, 2026 | May 28, 2026 |
| MiniMed Group, Inc.MMED · Entity 3758 | Director | March 06, 2026 | March 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Medtronic plc
Report date May 26, 2026 · Filed May 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 82,183 |
Reported balance
After 2026-05-26 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-26 · Exercise / conversion · Acquired 26,907 · Balance 82,183 F1: Represents shares issued upon the settlement of performance-vesting share units granted on July 31, 2023, based on performance as certified on May 26, 2026. F2: Includes 527 shares acquired through dividend reinvestment since the last report filed by the reporting person. |
| Performance Share UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-05-26 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-26 · Exercise / conversion · Disposed 24,214 · Balance 0 F3: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F4: The performance share units vested on April 24, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares issued upon the settlement of performance-vesting share units granted on July 31, 2023, based on performance as certified on May 26, 2026.
F2: Includes 527 shares acquired through dividend reinvestment since the last report filed by the reporting person.
F3: Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
F4: The performance share units vested on April 24, 2026.
MiniMed Group, Inc.
Report date March 06, 2026 · Filed March 06, 2026
This filing explicitly reported no securities owned.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2021 Filed Jun 2, 2021 22:00 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 2,473 | $128.07 | $316,717.11 |
DisclosureSEC source: 0001127602-21-018780 · form4.xml · nonDerivative · entry 3 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,487 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| May 28, 2021 Filed Jun 2, 2021 22:00 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 12,300 | $0.00 Strike: $47.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018780 · form4.xml · derivative · entry 4 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 12,300 shares Expires 2023-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| May 28, 2021 Filed Jun 2, 2021 22:00 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 7,355 | $126.59 | $931,069.45 |
DisclosureSEC source: 0001127602-21-018780 · form4.xml · nonDerivative · entry 2 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,960 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| May 28, 2021 Filed Jun 2, 2021 22:00 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 12,300 | $47.00 | $578,100.00 |
DisclosureSEC source: 0001127602-21-018780 · form4.xml · nonDerivative · entry 1 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,315 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · balance_after: This balance increased by 300 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| November 03, 2020 Filed Nov 5, 2020 23:15 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 229 | $103.13 | $23,616.77 |
DisclosureSEC source: 0001127602-20-028283 · form4.xml · nonDerivative · entry 1 Wall Brett A. · CIK 0001473812 · EVP & Group Pres Restora Thera 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,715 F1 · balance_after: This balance increased by 88 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| October 09, 2020 Filed Oct 14, 2020 23:09 UTC | Medtronic plc MDT · Entity 2888 | GrantPerformance Share Units · Derivative | 14,723 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-026962 · form4.xml · derivative · entry 1 Wall Brett A. · CIK 0001473812 · EVP & Group Pres Restora Thera 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,723 Underlying: Performance Share Units · 14,723 shares Expires not disclosed F1 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F2 · shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 14,723 shares will be issued. The actual number of shares to be issued could range from a low of 2,945 at minimum performance to a high of 29,446 shares at maximum performance. If minimum performance metrics are not met, such PSUs may vest at 0 shares. F3 · derivative.exercise_date: Vests on August 3, 2023. F3 · derivative.expiration_date: Vests on August 3, 2023. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 21:12 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 23,930 | $0.00 Strike: $97.33 | $0.00 |
DisclosureSEC source: 0001127602-20-022929 · form4.xml · derivative · entry 4 Wall Brett A. · CIK 0001473812 · EVP & Group Pres Restora Thera 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,930 Underlying: Ordinary Shares · 23,930 shares Expires 2030-08-03 F2 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 21:12 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 1,575 | $0.00 Strike: $97.33 | $0.00 |
DisclosureSEC source: 0001127602-20-022929 · form4.xml · derivative · entry 3 Wall Brett A. · CIK 0001473812 · EVP & Group Pres Restora Thera 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,575 Underlying: Ordinary Shares · 1,575 shares Expires 2030-08-03 F2 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 21:12 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 60,453 | $0.00 Strike: $97.33 | $0.00 |
DisclosureSEC source: 0001127602-20-022929 · form4.xml · derivative · entry 2 Wall Brett A. · CIK 0001473812 · EVP & Group Pres Restora Thera 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,453 Underlying: Ordinary Shares · 60,453 shares Expires 2030-08-03 F2 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 21:12 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 6,576 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-022929 · form4.xml · nonDerivative · entry 1 Wall Brett A. · CIK 0001473812 · EVP & Group Pres Restora Thera 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,856 F1 · kind: The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date. Read SEC document |
| July 31, 2020 Filed Aug 3, 2020 22:08 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 1,100 | $96.48 | $106,128.00 |
DisclosureSEC source: 0001127602-20-022613 · form4.xml · nonDerivative · entry 1 Wall Brett A. · CIK 0001473812 · EVP & Group Pres Restora Thera 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,280 F1 · balance_after: This balance increased by 205 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.